China National Accord Medicines Corp Ltd (SZSE:000028) Share Price

Company Profile

Business description
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Contact
No. 15, Ba Gua Si 4th Road
Accord Pharmaceutical Building
Futian District
Guangdong Province
Shenzhen518029
CHN
T: +86 75525875140
http://www.szaccord.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
34,831

Recommended

From cloud computing growth to AI monetization, here’s what we’re looking for in Alphabet’s upcoming earnings report.

Malik Ahmed Khan, CFA | 28 January 2026

Investors will get to see if the new strategy and capital management framework are working.

Brian Han | 27 January 2026

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,250.60	50.70	-0.55%
CAC 40	8,066.68	86.14	-1.06%
DAX 40	24,822.79	71.65	-0.29%
Dow JONES (US)	49,013.60	10.19	0.02%
FTSE 100	10,154.43	53.37	-0.52%
HKSE	27,826.91	699.96	2.58%
NASDAQ	23,881.45	64.35	0.27%
Nikkei 225	53,358.71	25.17	0.05%
NZX 50 Index	13,412.87	98.01	-0.73%
S&P 500	6,980.23	1.63	0.02%
S&P/ASX 200	8,933.90	40.40	-0.45%
SSE Composite Index	4,151.24	11.33	0.27%